soul study semaglutide flow trial kidney outcomes The rationale, design and baseline data of FLOW, a with once-weekly in people with type 2 diabetes and chronic kidney disease trial oral semaglutide cardiovascular – SOUL (Semaglutide cardiOvascular oUtcomes triaL)
Pay in 4 interest-free payments of $5.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
























